ETIOLOGY AND PATHOGENESIS OF CONGENITAL PNEUMONIA. CHARACTERISTICS IN PREMATURE BABIES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Congenital pneumonia is one of the main causes of high neonatal morbidity and mortality. The incidence of congenital pneumonia is about 1% among full-term infants and about 10% in premature infants and it is the cause of 10-38% of neonatal deaths. The etiological factor of this nosological entity can be bacteria, viruses, protozoa and fungi. The onset of clinical manifestations of congenital pneumonia depends on the period of action of the infectious agent (in utero, intranatally), as well as on the taxonomic characteristics of the pathogens. The lack of anti-infective protection in premature newborns, especially extremely and very premature ones, allows us to consider them as a specific group of immunocompromised patients, in whom congenital pneumonias occur more often and run a more severe course. In comparison with full-term babies, premature ones have some pathogens (ureaplasma, mycoplasma) that are often associated with the development of bronchopulmonary dysplasia in the outcome of congenital pneumonia. In addition, congenital infections caused by the same pathogen in premature infants can run a fulminant course, be accompanied by septic shock, respiratory distress syndrome, and death occurring within a few hours. This review of the literature presents an update on the etiology and pathogenesis of congenital pneumonia in newborn infants. Understanding the presented links of pathogenesis will be able to timely and correctly perform treatment in such babies.

Full Text

Restricted Access

About the authors

Nataliya A. Shilova

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation

Email: shilova37@gmail.com
PhD in Medicine, Senior Researcher of the Department of Neonatology and Clinical Neurology of Children's Age, Professor of the Department of Obstetrics and Gynecology, Neonatology, Anesthesiology and Resuscitation 153000, Russia, Ivanovo, Pobedy sqr., 20

Artyom V. Andreev

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation

Email: andreyevar@gmail.com
anesthesiologist-resuscitator of the Department of Resuscitation and Intensive Care of the Newborn, Post-graduate student of the Department of Obstetrics and Gynecology, Neonatology, Anesthesiology and Resuscitation 153000, Russia, Ivanovo, Pobedy sqr., 20

Natalya V. Kharlamova

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation

Email: nataliakhar13@yandex.ru
MD, PhD, Dr. Med. Sci., Head of the Department of Neonatology and Clinical Neurology of Children, Professor of the Department of Obstetrics and Gynecology, Neonatology, Anesthesiology and Resuscitation 153000, Russia, Ivanovo, Pobedy sqr., 20

Lyudmila A. Sytova

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation

Email: lusytta@mail.ru
PhD in Medicine, associate Professor of the Department of Obstetrics and Gynecology, Neonatology, Anesthesiology and Resuscitation 153000, Russia, Ivanovo, Pobedy sqr., 20

Anna A. Pesenkina

V.N. Gorodkov Ivanovo Research Institute of Maternity and Childhood, Ministry of Health of the Russian Federation

Email: anna.pesenkina@gmail.com
student, Department of Obstetrics and Gynecology, Neonatology, Anesthesiology and Resuscitation 153000, Russia, Ivanovo, Pobedy sqr., 20

References

  1. Щеголев А.И., Туманова У.Н., Шувалова М.П., Фролова О.Г. Врожденная пневмония как причина перинатальной смертности в Российской Федерации. Неонатология: новости, мнения, обучение. 2016; 2: 61-6
  2. Глуховец Б.И., Белоусова Н.А., Попов В.Г. Основные причины смерти новорожденных с экстремально низкой массой тела. Российский вестник перинатологии и педиатрии. 2004; 49(5): 61
  3. Nissen M.D. Congenital and neonatal pneumonia. Paediatr. Respir. Rev. 2007; 8(3): 195-203.
  4. GBD. 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013. Lancet. 2015; 385(9963): 117-71. https://dx.doi.org/10.1016/ S0140-6736(14)61682-2.
  5. Антонов А.Г., Байбарина Е.Н., Балашова Е.Н., Дегтярев Д.Н., Зубков В.В., Иванов Д. О., Ионов О.В., Карпова А.Л., Киртбая А.Р., Крохина К.Н., Крючко Д.С., Ленюшкина А.А., Ли А.Г., Малютина Л.В., Мебелова И.И., Никитина И.В., Петренко Ю.В., Рындин А.Ю., РюминаИ.И., Романенко А.В. Врожденная пневмония (клинические рекомендации). Неонатология: новости, мнения, обучение. 2017; 4: 133-48.
  6. Hooven T., Polin R. Pneumonia. Semin. Fetal Neonatal Med. 2017; 4: 133-48. https://dx.doi.org/10.1016/j.siny.2017.03.002.
  7. Curfman A.L., Glissmeyer E.W., Ahmad F.A., Korgenski E.K., Blaschke A.J., Byington C.L. et al. Initial presentation of neonatal herpes simplex virus infection. J. Pediatr. 2016; 172: 121-6. https://dx.doi.org/10.1016/jopeds.2016.02.015.
  8. Самсыгина Г.А. Пневмонии у детей. М.: ГЭОТАР-Медиа; 2018. 176 с. [Samsygina G.A. Pneumonia in children. Moscow: GEOTAR-Media; 2018. 176 p. (in Russian)].
  9. Beck-Sague С., Robinson А. Sexually transmissible infections in infants, children and adolescents. In: Morse S.A., Ballard R.C., Holmes K.K., Moreland A.A., eds. Atlas of sexually transmitted diseases and AIDS. 4th ed. Elsevier Health Sciences; 2010: 187-324.
  10. Волянюк Е.В., Сафина А.И. Врожденная пневмония у недоношенных новорожденных: особенности этиологии, диагностики и лечения. Практическая медицина. 2011; 5: 55-9.
  11. Кудашов H.H., Зубков В.В., Помелова В.Г., Ванько Л.В. Клиникодиагностическая характеристика пневмонии у новорожденных при герпетических инфекциях. Педиатрия. 2001; 3: 8-13
  12. Mendz G.L., Kaakoush N.O., Quinlivan J.A. Bacterial aetiological agents of intraamniotic infections and preterm birth in pregnant women. Front. Cell. Infect. Microbiol. 2013; 3: 58. https://dx.doi.org/10.3389/ fcimb.2013.00058.
  13. Тирская Ю.И., Баринов С.В., Долгих Т.И., Овчинникова Е.М. Исследование лактоферина и ФНО в околоплодных водах и сыворотке крови, как возможность факторов риска развития хориоамнионита у рожениц высокого инфекционного риска. Мать и дитя в Кузба^е. 2012; 4: 47-51.
  14. Kim C.J., Romero R., Chaemsaithong P., Chaiyasit N., Yoon B.H., Kim Y.M. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am. J. Obstet. Gynecol. 2015; 213(4, Suppl.): S29-52. https:// dx.doi.org/10.1016/j.ajog.2015.08.040.
  15. Семенова А.Л., Зарубина Е.Н., Павлович С.В. Современные взгляды на этиологию, диагностику и лечение хориоамнионита во II триместре беременности. Кремлевская медицина. Клинический вестник. 2008; 2: 63-6.
  16. Han Y.W., Shen T., Chung P., Buhimschi I.A., Buhimschi C.S. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J. Clin. Microbiol. 2009; 47(1): 38-47. https://dx.doi.org/10.1128/ JCM.01206-08.
  17. Перепелица С.А. Этиологические и патогенетические перинатальные факторы развития внутриутробных инфекций у новорожденных (обзор). Общая реаниматология. 2018; 14(3): 54-67.
  18. ОсипчукД.О., Слабинская Т.В. Проблема амниорексиса при недоношенной беременности: предрасполагающие факторы, перспективы прогнозирования хориоамнионита (научный обзор). Вестник уральской академической медицинской науки. 2014; 1: 79-84
  19. Кузьмин В.Н., Арсланян К.Н., Харченко Э.И., Адамян Л.В. Роль стрептококка группы Ввразвитии внутрибольничных инфекций. Молекулярная генетика, микробиология и вирусология. 2016; 4: 142-8
  20. Liu M.D., Xu F.L., Duan W.L., Liu J.X., Li X.N., Liu Y.X. et al. Risk factors for poor prognosis of neonatal bacterial meningitis. Zhongguo Dang Dai ErKeZaZhi. 2019; 21(11): 1064-8.
  21. Walker K.F., Morris E., Plumb J., Gray J., Thornton J.G., Daniels J. Universal testing for group B streptococcus during pregnancy: need for a randomised trial. BJOG. 2020; 127(6): 693. https://dx.doi.org/10.1111/1471-0528.16116.
  22. Remington J.S., Klein J.O., Wilson C.B., Nizet V., Maldonado Y. Infectious diseases of the fetus and newborn. 7th ed. Philadelphia: Elsevier Saunders; 2011. 1280p.
  23. Nader R., Tondeur S., Barrans A., Gevaudan A.R., Lamy B. Streptococcus pneumoniae neonatal infection. Ann. Biol. Clin. 2005; 63(6): 643-6.
  24. Samonini A., Grosse C., Aschero A., Boubred F., Ligi I. Congenital pneumonia owing to mycoplasma pneumonia. J. Pediatr. 2018; 203: 460. e1. https://dx.doi. org/10.1016/j.jpeds.2018.06.055.
  25. Гладков С.А. Беременность и грипп: патоморфологические проявления инфекции, вызванной вирусом А/Ш N1. Журнал акушерства и женских болезней. 2014; 63(3): 26-35.
  26. Memoli M.J., Harvey H., Morens D.M., Taubenberger J.K. Influenza in pregnancy. Influenza Other Respir. Viruses. 2013; 7(6): 1033-9. https://dx.doi. org/10.1111/irv.12055.
  27. Englund J., Chu H. Respiratory virus infection during pregnancy: does it matter? J. Infect. Dis. 2018; 218(4): 512-5. https://dx.doi.org/10.1093/infdis/jiy169.
  28. Кошелева Н.Г., Зубжицкая Л.Б. Исходы беременности, иммуноморфологическое состояние плаценты после острой респираторно-вирусной инфекции, перенесенной беременной, профилактика, лечение. Журнал акушерства и женских болезней. 2005; 54(3): 12-8.
  29. Schwartz D., Graham A. Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020; 12(2): 194. https://dx.doi.org/10.3390/v12020194.
  30. Reiterer F. Neonatal pneumonia. Intech Open; 2013.106p. https:// dx.doi.org/10.5772/54310.
  31. Piperaki E.T., Daikos G.L. Malaria in Europe: emerging threat or minor nuisance? Clin. Microbiol. Infect. 2016; 22(6): 487-93. https://dx.doi. org/10.1016/j.cmi.2016.04.023.
  32. Баранова А.М., Сергиев В.П., Гузеева Т.М., Токмалаев А.К. Клиническая настороженность к завозной малярии: прививные случаи и смертельные исходы в России. Инфекционные болезни: новости, мнения, обучение. 2018; 7(4): 97-101.
  33. HangiM., Achan J., SarutiA., Quinlan J., Idro R. Congenital malaria in newborns presented at Tororo General Hospital in Uganda: a cross-sectional study. Am. J. Trop. Med. Hyg. 2019; 100(5): 1158-63. https://dx.doi.org/10.4269/ Ёajtmh.17-0341.
  34. Chen S.N., Wang P.H., Hsieh M.F., Tsai H.W., Lin L.T., Tsui K.H. Maternal pregnancy-induced hypertension increases the subsequent risk of neonatal candidiasis: A nationwide population-based cohort study. Taiwan. J. Obstet. Gynecol. 2019; 58(2): 261-5. https://dx.doi.org/10.1016/ j.tjog.2019.01.017.
  35. Barton M., Shen A., Obrien K., Robinson J.L., Davies H.D., Simpson K. Early onset invasive candidiasis in extremely low birth weight infants: perinatal acquisition predicts poor outcome. Clin. Infect. Dis. 2017; 64(7): 921-7. https:// dx.doi.org/10.1093/cid/cix001.
  36. Никитина И.В., Ионов О.В, Приходько Н.А. Современные подходы к диагностике, терапии и профилактике инвазивных микозов у новорожденных. Неонатология: новости, мнения, обучение. 2014; 4: 64-72
  37. Maki Y., Fujisaki M., Sato Y., Sameshima H. Candida chorioamnionitis leads to preterm birth and adverse fetal-neonatal outcome. Infect. Dis. Obstet. Gynecol. 2017; 2017: 9060138. https://dx.doi.org/10.1155/2017/9060138.
  38. Zemans R., Henson P.,Henson J., Janssen W. Conceptual approaches to lung injury and repair. Ann. Am. Thorac. Soc. 2015; 12(Suppl. 1): S9-15. https:// dx.doi.org/10.1513/AnnalsATS.201408-402MG.
  39. Whidbey С., Vornhagen J., Gendrin C., Boldenow E., Samson J., Doering K. et al. A streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury. EMBO Mol. Med. 2015; 7: 488-505. https:// dx.doi.org/10.15252/emmm.201404883.
  40. Massler A., Kolodkin-Gal D., Meir K., Khalaileh A., Falk H., Izhar U. et al. Infant lungs are preferentially infected by adenovirus and herpes simplex virus type 1 vectors: role of the tissue mesenchymal cells. J. Gene Med. 2011; 13(2): 101-13. https://dx.doi.org/10.1002 / jgm.1544.
  41. Han S., Mallampalli R.K. The role of surfactant in lung disease and host defense against pulmonary infections. Ann. Am. Thorac. Soc. 2015; 12(5): 765-74. https://dx.doi.org/10.1513/AnnalsATS.201411-507FR.
  42. Kuang Z., Hao Y., Walling B., Jeffries J., Ohman D., Lau G. Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A. PLoS One. 2011; 6(11): e27091. https://dx.doi.org/10.1371/journal.pone.0027091.
  43. Bernhard W. Lung surfactant: Function and composition in the context of development and respiratory physiology. Ann. Anat. 2016; 208: 146-50. https:// dx.doi.org/10.1016/j.aanat.2016.08.003.
  44. Collins A., Weitkamp J.H., Wynn J.L. Why are preterm newborns at increased risk of infection? Arch. Dis. Child Fetal Neonatal Ed. 2018; 103(4): F391-4. https:// dx.doi.org/10.1136/archdischild-2017-313595.
  45. Никитина И.В., Жукова А.С., Ванько Л.В., Вторушина В.В., Матвеева Н.К., Кречетова Л.В., Крючко Д.С., Ионов О.В., Зубков В.В., Дегтярев Д.Н. Особенности цитокинового статуса у недоношенных новорожденных с заболеваниями легких инфекционного и неинфекционного генеза. Неонатология: новости, мнения, обучение. 2018; 6(4): 16-23.
  46. Овсянников Д.Ю., Кравчук Д.А., Николаева Д.Ю. Клиническая патофизиология органов дыхания недоношенных детей. Неонатология: новости, мнения, обучение. 2018; 6(3): 74-98
  47. Derscheid R.J., Ackermann M.R. The innate immune system of the perinatal lung and responses to respiratory syncytial virus infection. Vet. Pathol. 2013; 50(5): 827-41. https://dx.doi.org/10.1177/0300985813480216.
  48. Kohl J. Anaphylatox in sand infectious and non-infectious inflammatory diseases. Mol. Immunol. 2001; 38(23): 175-87. https://dx.doi.org/10.1016/ s0161-5890 (01) 00041-4.
  49. Siauw C., Kobsar A., Dornieden C., Beyrich C., Schinke B., Schubert-Unkmeir A. et al. Group B streptococcus isolates from septic patients and healthy carriers differentially activate platelet signaling cascades. Thromb. Haemost. 2006; 95: 836-49. https://dx.doi.org/10.1160 / th05-08-0534.
  50. Kollmann T.R., Kampmann B., Mazmanian S.K., Marchant A., Levy O. Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny. Immunity. 2017; 46: 350-63. https://dx.doi.org/10.1016/j. immuni.2017.03.009.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies